Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

David F Archer, Ruth B Merkatz, Luis Bahamondes, Carolyn L Westhoff, Philip Darney, Dan Apter, Jeffrey T Jensen, Vivian Brache, Anita L Nelson, Erika Banks, György Bártfai, David J Portman, Marlena Plagianos, Clint Dart, Narender Kumar, George W Creasy, Regine Sitruk-Ware, Diana L Blithe

Open source

DOI: 10.1016/s2214-109x(19)30265-7
Published: 2019-08
Container: The Lancet Global Health
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2214-109x-19-30265-7,
  title = {Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials},
  author = {David F Archer and Ruth B Merkatz and Luis Bahamondes and Carolyn L Westhoff and Philip Darney and Dan Apter and Jeffrey T Jensen and Vivian Brache and Anita L Nelson and Erika Banks and György Bártfai and David J Portman and Marlena Plagianos and Clint Dart and Narender Kumar and George W Creasy and Regine Sitruk-Ware and Diana L Blithe},
  year = {2019},
  journal = {The Lancet Global Health},
  doi = {10.1016/s2214-109x(19)30265-7},
  url = {https://doi.org/10.1016/s2214-109x(19)30265-7}
}

RIS

TY  - JOUR
TI  - Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials
AU  - David F Archer
AU  - Ruth B Merkatz
AU  - Luis Bahamondes
AU  - Carolyn L Westhoff
AU  - Philip Darney
AU  - Dan Apter
AU  - Jeffrey T Jensen
AU  - Vivian Brache
AU  - Anita L Nelson
AU  - Erika Banks
AU  - György Bártfai
AU  - David J Portman
AU  - Marlena Plagianos
AU  - Clint Dart
AU  - Narender Kumar
AU  - George W Creasy
AU  - Regine Sitruk-Ware
AU  - Diana L Blithe
PY  - 2019
JO  - The Lancet Global Health
DO  - 10.1016/s2214-109x(19)30265-7
UR  - https://doi.org/10.1016/s2214-109x(19)30265-7
ER  -

APA

Archer, D. F., Merkatz, R. B., Bahamondes, L., Westhoff, C. L., Darney, P., Apter, D., Jensen, J. T., Brache, V., Nelson, A. L., Banks, E., Bártfai, G., Portman, D. J., Plagianos, M., Dart, C., Kumar, N., Creasy, G. W., Sitruk-Ware, R., & Blithe, D. L. (2019). Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(19)30265-7

Source records

crossref · retrieved 2026-09-26T09:23:42.703Z